Screener
Tango Therapeutics TNGX Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Tango Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Tango Therapeutics’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221656
FAQ
- What is Tango Therapeutics's debt-to-equity?
- Tango Therapeutics (TNGX) reported debt-to-equity of 0.1× in Q1 2026.
- How has Tango Therapeutics's debt-to-equity changed year-over-year?
- Tango Therapeutics's debt-to-equity decreased by 62.2% year-over-year, from 0.2× to 0.1×.
- What is the long-term trend for Tango Therapeutics's debt-to-equity?
- Over 5 years (2020 to 2025), Tango Therapeutics's debt-to-equity has grown at a -13.8% compound annual growth rate (CAGR), from 0.2× to 0.1×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Tango Therapeutics's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude